• In mice, 7 × 19 CAR-T cells achieved complete regression of pre-established solid tumors and prolonged mouse survival, with superior anti-tumor activity compared to conventional CAR-T cells. (nature.com)
  • It is possible that poor effects or lack of durability of CAR-T cell therapies for solid tumors in other mouse models can be explained by the lack of human IL-2. (taconic.com)
  • Solid tumors pose significant challenges for immunotherapies including those employing phagocytic macrophages as effector cells. (aiche.org)
  • Thus, our in vitro and in vivo models utilizing gene-edited cells, monoclonal antibodies for opsonization and checkpoint blockade, and cell therapy begin to define the parameters required for successful immunotherapy of solid tumors including (i) macrophage density, (ii) inhibitory checkpoint disruption, and (iii) IgG-opsonization. (aiche.org)
  • These armed second-generation CAR T cells empowered to secrete human anti-PD-L1 antibodies in the ccRCC milieu to combat T cell exhaustion is an innovation in this field that should provide renewed potential for CAR T cell immunotherapy of solid tumors where limited efficacy is currently seen. (oncotarget.com)
  • The possibility that suppression was also an in vivo mechanism for tolerance was studied by adoptive transfer experiments. (nih.gov)
  • While their initial research studied melanoma, Forsberg is interested to study other cancers and combination therapies in this mouse model 1 . (taconic.com)
  • Moreover, we were also interested to study the use of CAR-T therapies in uveal melanoma in the immune-humanized mouse model, an uncommon type of melanoma arising in the eye. (taconic.com)
  • We are also interested to test other types of immunotherapies and combination therapies in this model. (taconic.com)
  • Conclusions Our results demonstrate a novel way to use TLR agonists to improve immunotherapy and reveal a vital role for B cells in the generation of potent CD8 + T cell-based therapies. (bmj.com)
  • The Novina Lab is using CRISPR-Cas9 based systems to develop novel approaches to regulate key inhibitory genes for adoptive cellular therapies. (dana-farber.org)
  • While conventional animal models have identified an array of potential anti-tumor therapies, mouse models often fail to translate into effective human treatments. (biomedcentral.com)
  • On average, the mice that received the triple-combination therapy (MEK inhibitor trametinib + BRAF inhibitor dabrafenib + immunotherapy, either anti-PD1 antibody or tumor antigen-specific adoptive cell transfer) lived at least twice as long as those that received the double-combination therapies. (nih.gov)
  • Cancer immunotherapies can be divided into four major categories: - Cytokines/immunomodulation agents - Monoclonal antibodies - Cell‑based therapies - Oncolytic viruses Though monoclonal antibodies currently represent the largest class of commercialized cancer immunotherapies, cell‑based therapies are rapidly making headway. (technologynetworks.com)
  • The successful campaign of adoptive T cell therapies, a type of immunotherapy in which immune T cells are collected from a patient, enhanced outside of the body, and reinfused back into the same patient, especially against blood cancers is well under way. (sciencedaily.com)
  • Our study provides a conceptual basis for future strategies aiming to create functionally distinct T cell populations for adoptive therapies by selectively tuning mechanical input provided by biomaterials-based engineered cell culture systems. (sciencedaily.com)
  • Insights gained from these experiments will provide a blueprint for designing novel immunotherapies including cancer vaccines, tumor targeting antibodies, and adoptive cell therapies. (51fangxue.com)
  • All the above-mentioned cells are estimated to be important for the adoptive TIL transfer therapies. (kuickresearch.com)
  • We now investigate whether inhibition of Akt signaling during ex vivo expansion of CAR T cells can promote the generation of CAR T cells with enhanced antitumor activity following adoptive therapy in a murine leukemia xenograft model. (biomedcentral.com)
  • To evaluate anti-CD19-CAR-transduced T cells in a murine model of adoptive T-cell therapy, we developed a CAR that specifically recognized murine CD19. (ashpublications.org)
  • We used T cells that were retrovirally transduced with this CAR to treat mice bearing a syngeneic lymphoma that naturally expressed the self-antigen murine CD19. (ashpublications.org)
  • To establish a murine model in which a completely syngeneic lymphoma could be treated by adoptive transfer of syngeneic CAR-transduced T cells, we developed a CAR that could specifically recognize murine CD19. (ashpublications.org)
  • Parameters examined on mice transplanted with murine mammary adenocarcinoma (AMN3) cells (to study the therapeutic of CXCL11 in vivo) were included growth inhibition (GI%), relative tumor volume (RTV), relative mice weight (RMW) and survival time in mice. (iraqijms.com)
  • Following treatment of mice with 7 × 19 CAR-T cells, both recipient conventional T cells and administered CAR-T cells generated memory responses against tumors. (nature.com)
  • According to Elin Forsberg, a doctoral student working in the lab of Dr. Jonas Nilsson at the University of Gothenburg, IL-2 transgenic humanized NOG mice can be used to study the effect of CAR-T therapy on human tumors. (taconic.com)
  • One notable observation was that in the immune-humanized mouse model, mice receiving T cells would develop a lymphoproliferative disease after the tumors disappeared because the IL-2 signaling was constitutive, driving T cell proliferation. (taconic.com)
  • Upon mRNA intratumoral injections in the transplantable mouse cancer models CT26, MC38, and B16OVA, potent therapeutic effects were observed following repeated injections into the tumors. (unav.edu)
  • Although IL-12 given alone to mice bearing tumors established for 3 days did not have consistent antitumor activity, a profound therapeutic effect was observed when IL-12 administration was combined with a recombinant vaccinia virus (rVV) encoding beta-gal called VJS6. (univr.it)
  • Micropipette aspiration rheology of cell clusters and freshly isolated mouse tumors revealed viscoelasticity and cell cohesion in both tissues. (aiche.org)
  • Anti-tumor IgG administered intravenously to mice eliminated a fraction of CD47 knockout tumors in vivo but had no effect on wild-type tumors. (aiche.org)
  • We were the first to show that administration of bortezomib, a proteasome inhibitor, in mice bearing mammary and renal tumors sensitized tumor cells to apoptosis by amplifying tumor cell caspase-8 activation following treatment with TRAIL receptor agonist antibody (JNCI 100:649). (vumc.org)
  • The demonstration of anergic T lymphocytes following oral tolerance has so far been limited in in vitro systems, and a primary objective of the present study was to provide evidence, in vivo, for the existence of a state of anergy in mice orally fed with ovalbumin (OVA). (nih.gov)
  • Reversal of the tolerant state in vivo was established by antibody production in irradiated mice adoptively transferred with cells cultured in the presence of rIL-2. (nih.gov)
  • Immunotherapy based on the adoptive transfer of ex vivo expanded and activated autologous tumor-reactive lymphocytes can mediate tumor regression in cancer patients. (unimedizin-mainz.de)
  • Here, we used reflectance confocal microscopy (RCM) imaging in humans and in mice to visualize tumor architecture in vivo . (bioxcell.com)
  • Following up on our previous work (https://www.nature.com/articles/s41586-022-04839-2), we have developed novel mouse strains that enable precise interrogation of protein synthesis and antigen presentation from cancer cells in vivo. (51fangxue.com)
  • In vivo, DIDS administration delayed B16OVA tumor growth in immunocompetent mice as monotherapy or when combined with adoptive T cell transfer of OVA-specificT cells. (unav.edu)
  • The Mouse Cytokine Array, Panel A utilizes capture antibodies spotted onto a nitrocellulose membrane to allow high-throughput multi-analyte profiling of 40 cytokines, chemokines, and more in a single sample. (rndsystems.com)
  • Mouse splenocytes treated with 100 ng/mL LPS for 20 hours were mixed with a cocktail of biotinylated detection antibodies, and then incubated with the Mouse Cytokine Array. (rndsystems.com)
  • Intratumoral immunotherapy strategies for cancer based on interleukin-12 (IL-12)-encoding cDNA and mRNA are under clinical development in combination with anti-PD-(L)1 monoclonal antibodies. (unav.edu)
  • We are also working on a novel technique for isolation of therapeutic antibodies from patients who respond to immunotherapies, based on the observation that such patients can mount immune responses against inhibitory immune molecules (Wucherpfennig and Dranoff Labs). (dana-farber.org)
  • Besides surgery, radiotherapy and chemotherapy, immune activation by direct application of cytokines, antibodies or adoptive cell therapy are promising approaches. (frontiersin.org)
  • Promising immunotherapy strategies for Compact disc19-positive hematological malignancies are the adoptive transfer of T cells that are genetically improved to express Compact disc19-particular chimeric antigens receptors (Vehicles) or the infusion of bispecific antibodies that redirect citizen T cells to Compact disc197,8,9,10,11,12,13,14,15. (bso14.org)
  • Herein we used a single bicistronic lentiviral vector to develop a new combination immunotherapy that consists of human anti-carbonic anhydrase IX (CAIX)-targeted chimeric antigen receptor (CAR) T cells engineered to secrete human anti-programmed death ligand 1 (PD-L1) antibodies at the tumor site. (oncotarget.com)
  • A membrane-based antibody array for the parallel determination of the relative levels of selected mouse cytokines and chemokines. (rndsystems.com)
  • NK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma model. (rndsystems.com)
  • CD137 agonists attain immunotherapeutic antitumor effects in cancer mouse models, and multiple agents of this kind are undergoing clinical trials. (unav.edu)
  • Antitumor effects of agonist anti-CD137 mAbs are critically dependent on the integrity of cIAPs in cancer mouse models, and cIAPs are also required for signaling from CARs encompassing CD137's cytoplasmic tail. (unav.edu)
  • Significantly, the chimeric antigen receptorCengineered antitumor Compact disc8+ Capital t cells extended via transient 475205-49-3 manufacture excitement shown excellent perseverance and antitumor reactions in adoptive immunotherapy mouse versions. (bioskinrevive.com)
  • Among these populations, TSCM cells have excellent perseverance and antitumor results in multiple malignancy immunotherapy versions (12C18). (bioskinrevive.com)
  • Once adoptively transferred into CD19+ tumor-bearing mice, Akti treated CD19CAR T cells exhibited more antitumor activity than did untreated CD19CAR T cells. (biomedcentral.com)
  • Epstein-Barr virus-specific iT SCM cells showed much stronger antitumor potentials than conventionally activated T cells in humanized Epstein-Barr virus transformed-tumor model mice. (elsevierpure.com)
  • The adoptive transfer of OVA-specificT cells overexpressing Hvcn1 exerted a better antitumor activity in B16OVA tumor-bearingmice. (unav.edu)
  • Hvcn1 overexpression also improved the antitumor activity of CAR T cells specific for Glypican 3 (GPC3) in mice bearing PM299L-GPC3tumors. (unav.edu)
  • Rosenberg, S.A. & Restifo, N.P. Adoptive cell transfer as personalized immunotherapy for human cancer. (nature.com)
  • We previously published an immune-humanized mouse model in which we transplanted tumor cells and autologous tumor-infiltrating lymphocytes (TILs) from patients in a clinical trial of adoptive T cell transfer (ACT) in Herlev, Denmark - and demonstrated that responses in IL-2 transgenic NOG mice correlated to the responses of the patients in the trial 2 . (taconic.com)
  • The major areas of recent interest in the lab have been augmentation of anti-tumor immune effects, the tumor microenvironment, mechanisms of T cell dysfunction, and adoptive T cell transfer with an increasing focus on lung cancer. (upenn.edu)
  • The lab has extensive experience in lentiviral transduction of human T cells and retroviral transduction of mouse T cells for use in adoptive T cell transfer. (upenn.edu)
  • Background Adoptive T cell transfer (ACT) therapy improves outcomes in patients with advanced malignancies, yet many individuals relapse due to the infusion of T cells with poor function or persistence. (bmj.com)
  • We develop a multifocal HCC model to test immunotherapies by introducing c-myc using hydrodynamic gene transfer along with CRISPR-Cas9-mediated disruption of p53 in mouse hepatocytes. (unav.edu)
  • Using HLA-A2.1 transgenic mice, we have demonstrated the feasibility of T-cell receptor (TCR) gene transfer into T cells to circumvent self-tolerance to the widely expressed human p53 and MDM2 TAAs. (unimedizin-mainz.de)
  • Here, we evaluated the safety issues raised by the risk of TAA-TCR gene transfer-associated on/off-target toxicities and the therapeutic potential in relevant transgenic mouse models of adoptive transfer. (unimedizin-mainz.de)
  • Our study indicates that IL-27 or adoptive transfer of IL-27 loaded tDCs may be a new therapeutic approach in atherosclerosis. (hindawi.com)
  • Treg deletion accelerates the development of atherosclerosis, and adoptive transfer Treg suppresses atherosclerosis [ 10 ]. (hindawi.com)
  • In the last years, adoptive transfer of natural killer (NK) cells came into the focus of translational medicine, because of their high cytotoxic potential against transformed malignant cells. (frontiersin.org)
  • Anti-tumor activity was evaluated after adoptive transfer of the CD19CAR T cells into CD19+ tumor-bearing immunodeficient mice. (biomedcentral.com)
  • Retargeting IL-2 Signaling to NKG2D-Expressing Tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy. (amedeo.com)
  • In one study [ 14 ], TIL from implanted tumor were able to migrate to spleen and maintained their characters even after adaptive transfer to another SCID mouse, providing a unique opportunity to investigate the function of TIL and test strategies to eradicate tumor. (biomedcentral.com)
  • Adoptive transfer of tumor antigen-specific stem cell memory T (T SCM ) cells is expected to overcome this shortcoming as T SCM cells are close to naïve T cells, but are also highly proliferative, long-lived, and produce a large number of effector T cells in response to antigen stimulation. (elsevierpure.com)
  • 12 , 13 Clinical trials in which patients with advanced B-cell malignancies receive T cells expressing anti-CD19 CARs are in early stages, and it is not known whether adoptive transfer of T cells targeting this self-antigen will be an effective therapy for B-cell malignancies. (ashpublications.org)
  • One potential technique to get Zoledronic Acid over these limitations may be the hereditary adjustment and adoptive transfer of T cells Zoledronic Acid that secrete diabodies20 or T-cell engagers (ENG T cells)21, since T cells can secrete substances at tumor sites positively, and persist for many weeks post infusion. (bso14.org)
  • Adoptive cell transfer therapy using CD8+ T lymphocytes showed promising results eradicating metastatic malignancies. (unav.edu)
  • He has conceived of and implemented transdisciplinary research directions by integrating tumor biology, immunology, bioengineering, computational biology, neuroscience and immunotherapy. (vumc.org)
  • Experience in tumor immunology, genetically engineered mouse models, protein purification, organoid culture and/or immunopeptidomics. (51fangxue.com)
  • The Cantor Lab has found that depletion of CD8 regulatory T cells enhances anti-tumor responses in mouse models and is studying approaches to modulate their function. (dana-farber.org)
  • However, the addi-tion of either recombinant IL-2 or an anti-CD137 mAb markedly improves both outcomes in these mice. (unav.edu)
  • These outcomes recommend that controlled excitement is definitely essential for producing Capital t cell grafts for ideal adoptive immunotherapy for malignancy. (bioskinrevive.com)
  • These results offer a preclinical proof for combining bortezomib or PCC with lymphocyte transfers to improve the outcomes of cancer immunotherapy. (vumc.org)
  • It is estimated from the outcomes received that the approach developed by the researchers have helped the cancer therapeutics and immunotherapy market to expand in the size and provide benefits to millions of patients. (kuickresearch.com)
  • Combining tumor-specific adoptive T cell therapy to the aCTLA-4/aPD1/rIL2 or aCTLA-4/aPD1/aCD137 reg-imens enhances efficacy in a synergistic manner. (unav.edu)
  • On the basis of the reported synergistic effects of IL-12 and the costimulatory molecule B7-1 (CD80) in vitro, we immunized mice with a double recombinant vaccinia encoding both the model tumor Ag and the costimulatory molecule B7-1, designated B7-1 beta-gal rVV. (univr.it)
  • While different methods exist to evaluate the efficacy of immunotherapy products, more efficient and robust in vitro assays are still required to ensure their safety and consistency. (technologynetworks.com)
  • This eBook highlights innovative tools to evaluate the potency of immunotherapies in vitro . (technologynetworks.com)
  • 6 ] successfully isolated OGSCs from the ovaries of pups and adult mice for the first time, transfected them with GFP virus in an appropriate environment in vitro, and then transplanted them into the ovaries of immunodeficient mice. (biomedcentral.com)
  • Indeed a wealth of studies from humans and mouse models establishes a particularly potent role for CD8 T cells in controlling the outgrowth of malignancies ( 3 ). (frontiersin.org)
  • In response to a cancer-germline self-antigen P1A, akin to human MAGE-like antigens, our pioneering studies using TCR-P1A transgenic mice (J Immunol 172:5069) established normal thymic development of CD8 T cells and discovered a paradigm of CD8 T cell help for innate NK effector function in solid tumor microenvironments. (vumc.org)
  • Adenosine limits the therapeutic effectiveness of anti-CTLA4 mAb in a mouse melanoma model. (rndsystems.com)
  • A Therapeutic Vaccine in Combination with Cyclic GMP-AMP Cures More Differentiated Melanomas in Mice. (amedeo.com)
  • Thus, adoptive T-cell therapy with iT SCM offers a promising therapeutic strategy for cancer immunotherapy. (elsevierpure.com)
  • Moreover, cIAPs are required for CD137 signaling toward the NF-?B and MAPK pathways and for costimulation of human and mouse T lymphocytes. (unav.edu)
  • As shown by multiplex tissue immunofluorescence and intravital microscopy, combined immunotherapy treatments enhance T cell infiltration and the intratumoral performance of T lymphocytes. (unav.edu)
  • CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy. (amedeo.com)
  • The immune system in NOD/SCID/IL-2Rγnull (NSG) mice was reconstituted by the co-administration of human peripheral blood lymphocytes (PBL) or subsets (CD4+ or CD8+) and autologous human dendritic cells (DC), and animals simultaneously challenged by implanting human prostate cancer cells (PC3 line). (biomedcentral.com)
  • Tumor infiltrating lymphocytes (TIL) are a universal feature of human cancers and may hold an important key to unlocking effective cancer immunotherapy [ 1 - 3 ]. (biomedcentral.com)
  • Our department is developing novel approaches for immunotherapy, and we closely collaborate with our clinical colleagues to advance important discoveries to clinical trials. (dana-farber.org)
  • We believe that this technology will substantially enhance our ability to study immunological mechanisms in patients enrolled in clinical trials of novel immunotherapies. (dana-farber.org)
  • We are also closely collaborating with our clinical colleagues to advance the development of novel cancer immunotherapies. (dana-farber.org)
  • Finally, it retrospectively analyze the activation strategies and clinical relevance of existing γδ T cell adoptive immunotherapies. (explorationpub.com)
  • The Jaeger Lab uses sophisticated mouse models, cutting edge mass spectrometry, next generation sequencing, patient derived organoids and clinical specimens to identify and characterize patterns of antigen presentation in the tumor microenvironment. (51fangxue.com)
  • In parallel, the Jaeger Lab uses human cells and clinical samples to explore opportunities to translate our findings in mouse models to the clinical setting. (51fangxue.com)
  • Early clinical trials sustain the concept of epigenetic enhancement of immunotherapy [ 20 , 21 ] yet the precise mechanism of action and the crucial cellular targets of epigenetic drugs remain unknown. (biomedcentral.com)
  • The purpose is to deliver chemotherapy, immunotherapy, and/or radiation to eliminate malignancy, prevent rejection of new stem cells, and create space for the new cells. (medscape.com)
  • Adoptive T-cell therapy with T cells expressing chimeric antigen receptors (CARs) is an active area of cancer research. (ashpublications.org)
  • The targeted disruption of a similar gene in mice leads to ulcerative colitis-like disease, which suggests a role in the immune response to antigenic stimuli. (thermofisher.com)
  • We successfully applied this strategy to the human TAAs p53, gp100 and MDM2-specific TCRs as promising antigens-driven immunotherapy for both melanoma and hematologic malignancies. (unimedizin-mainz.de)
  • Adoptive T-cell therapy with anti-CD19 chimeric antigen receptor (CAR)-expressing T cells is a new approach for treating advanced B-cell malignancies. (ashpublications.org)
  • Insufficient persistence and effector function of chimeric antigen receptor (CAR)-redirected T cells have been challenging issues for adoptive T cell therapy. (biomedcentral.com)
  • In conclusion, COS could significantly improve the ovarian and immune function of chemotherapy model mice, and improve the survival rate of OGSCs, which provided a preliminary blueprint for further exploring the mechanism of COS in protecting ovarian function. (biomedcentral.com)
  • This joint (Frankfurt/Mainz, Dresden, Essen, Heidelberg) translational immunotherapy project aims to combine NK cells as effector cells with universal epitope-specific CAR (UniCAR) with tunable activity. (unimedizin-mainz.de)
  • Mouse monoclonal antibody to AMACR. (bioskinrevive.com)
  • Converting an Anti-Mouse CD4 Monoclonal Antibody into an scFv Positron Emission Tomography Imaging Agent for Longitudinal Monitoring of CD4(+) T Cells. (amedeo.com)
  • The XMG1.2 monoclonal antibody reacts with mouse IFNγ (interferon gamma) a 20 kDa soluble pleiotropic cytokine and the sole member of the type II class of interferons. (bioxcell.com)
  • However, study on the effects of IL-27/anti-IL-27 antibody (anti-IL-27p28-Ab) administration to atherosclerosis model in ApoE -/- mice has not been reported. (hindawi.com)
  • Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice. (amedeo.com)
  • Injection of IFN-gamma into tumor-bearing mice or transgenic overexpression of Ncr1 in NK cells in mice resulted in decreased metastasis formation. (bioxcell.com)
  • hIL-2 NOG mice produce human IL-2 in the range of 0.5-2.0 ng/mL as measured by MFI serology testing on DBS and serum in February 2023. (taconic.com)
  • Methods: CXCL11 adoptive immunotherapy inducible, was intratumorally injected in mice breast cancer model one dose weekly for three weeks, each dose concentration 20 ng/100μl. (iraqijms.com)
  • Q: How do you see this model/approach impacting preclinical CAR-T and immunotherapy development? (taconic.com)
  • This fact has huge implications for research focusing on preclinical CAR-T (or other immunotherapy) development. (taconic.com)
  • Experimental Pharmacology & Oncology (EPO) GmbH uses 1st and 2nd generation NOG mice provided by Taconic for its preclinical oncology service. (taconic.com)
  • Intro Tumor immunotherapy, which intrusions the individuals personal immune system program to 475205-49-3 manufacture assault growth cells, is definitely a quickly growing treatment modality. (bioskinrevive.com)
  • The extensive analysis of the immune system has led to a conclusion that the expanding rate of tumor-specific antigen reactive T cells are capable of delivering success to all the immunotherapies. (kuickresearch.com)
  • In this work we intend to investigate this connection through the use of an immunostimulatory odorant like menthol, analyzing its impact on the immune system and the cognitive capacity in healthy and Alzheimer's Disease Mouse Models. (unav.edu)
  • TSCM infusion led to a more sustained reduction in tumor growth and correlated with a significant increase in overall survival of treated mice. (wikipedia.org)
  • We show that treatment of the mice with a combination of anti-CTLA-4 + anti-PD1 mAbs results in partial clearance of the tumor with an improvement in survival. (unav.edu)
  • Now, in a mouse study published in Science Translational Medicine , NIH-funded researchers at the University of California, Los Angeles (UCLA) provide renewed hope for a safe, effective combination therapy for melanoma-with a strategy that adds a third drug to the mix [4]. (nih.gov)
  • The platform developed by the researchers allow them to detect and isolate important tumor-reactive immune cells in order to advance the overall personalized immunotherapy in the patients. (kuickresearch.com)
  • Another thing that Drs. Ribas and Hu-Lieskovan found particularly encouraging was that, at least in mice, MEK inhibitors do not seem to impair the function of key immune cells called T cells. (nih.gov)
  • It is currently viewed as one of the most promising forms of cancer treatment with 12 cancer immunotherapies approved in recent years. (technologynetworks.com)
  • Basal adenosine modulates the functional properties of AMPA receptors in mouse hippocampal neurons through the activation of A1R A2AR and A3R. (rndsystems.com)
  • Human NK cells developed in hIL-2 NOG mice express various NK receptors and produce both granzyme A and perforin upon stimulation. (taconic.com)
  • High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. (nature.com)
  • CAR T cell (CAR-T) therapy is a relatively recent immunotherapy with the first drugs approved for human use by the FDA in 2017. (taconic.com)
  • It is an important observation that human IL-2 seems to be necessary for beneficial effects of human CAR-T cells in mice. (taconic.com)
  • Super immunodeficient NOG mouse expressing human IL-2 cytokine. (taconic.com)
  • Predominant differentiation of human NK cells following human HSC engraftment, with>10-fold higher CD56+ NK cell numbers compared to the base NOG mouse. (taconic.com)
  • The hIL-2 NOG mouse was developed by microinjecting a transgene consisting of a DNA fragment containing human IL-2 cDNA under the control of the CMV promoter into zygotes of NOD/ShiJic-Il2rg mice. (taconic.com)
  • mouse: an excellent recipient mouse model for engraftment of human cells. (taconic.com)
  • Fukuchi Y, Miyakawa Y, Kobayashi K, Kuramochi T, Shimamura K, Tamaoki N, Nomura T, Ueyama Y, Ito M. (1998) Cytokine dependent growth of human TF-1 leukemic cell line in human GM-CSF and IL-3 producing transgenic SCID mice. (taconic.com)
  • Katano I, Takahashi T, Ito R, Kamisako T, Mizusawa T, Ka Y, Ogura T, Suemizu H, Kawakami Y, Ito M. (2015) Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse. (taconic.com)
  • Current efforts focus on applying these insights to adoptive T cell therapy for human solid cancers. (dana-farber.org)
  • Here we show the methodological parameters of human CD8 + iT SCM cell generation and their application to adoptive cancer immunotherapy. (elsevierpure.com)
  • We demonstrated that signaling via the NK cell receptor NKp46 (human) and Ncr1 (mouse) induced interferon-gamma (IFN-gamma) secretion from intratumoral NK cells. (bioxcell.com)
  • Infusion of Compact disc19-ENG T cells led to regression of leukemia or lymphoma in xenograft versions and a success advantage compared to control mice. (bso14.org)